Askari, Neda <br/><br/>
Granisetron adjunct to fluvoxamine for moderate to severe obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled trial.  [electronic resource] 

 -  CNS drugs  Oct 2012 
 - 883-92 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1179-1934 
<br/><br/><label>Standard No.: </label>10.2165/11635850-000000000-00000  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Double-Blind Method<br/>Drug Synergism<br/>Female<br/>Fluvoxamine--adverse effects<br/>Granisetron--adverse effects<br/>Humans<br/>Male<br/>Obsessive-Compulsive Disorder--drug therapy<br/>Outcome Assessment, Health Care<br/>Serotonin 5-HT3 Receptor Antagonists--adverse effects